CHA Biotech wins government backing to advance cell and gene therapy platform

CHA Biotech has secured government funding for a three-and-a-half-year research project focused on advancing its cell and gene therapy platforms. This support is significant because it will enable the company to move closer to clinical development, a crucial step in bringing new treatments to market. The 31.5 billion won ($22.7 million) in funding will also help CHA Biotech stay competitive in the rapidly evolving biotechnology industry.

Why it matters

The government backing will help CHA Biotech advance its cell and gene therapy platform. This could lead to new treatments and increased investment in the biotech sector.

Market impact

Transmission channels

Likely winners & losers

Related coverage

• Todd Blanche wins backing of senators after scrapping $1.8bn ‘slush fund’ Financial Times · 2026-08-03

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to The Korea Times. For information only — not financial advice.